Middle East and North Africa Conference (MENA)

This two-day conference is designed for the industry's regulatory professionals to explore the evolving pharmaceutical landscape in the MENA region and address its unique challenges, with all regional regulators present.

Back to Agenda

Session 2: International Collaboration, Harmonisation & Convergence

Session Chair(s)

Dina Fathy, MPharm, AHIP

Senior Director, Regulatory Affairs Middle East Subregional Lead

MSD UAE, United Arab Emirates

Asmaa Fouad

General Manager, Biological and Innovative Products and Clinical Studies

Egyptian Drug Authority , Egypt

Topics addressed in this session include: Innovative pathways, Regional harmonisation initiatives, WHO benchmarking tool, opportunities and challenges for regional collaboration, updates from ICH Assembly.

Speaker(s)

Panel Discussion with Q&A

Representative Invited

Regional Harmonisation Initiatives: The North African Medicines Reguatory Harmonisation (NA-MRH) Initiative -Challenges & Opportunities

Representative Invited

African Union Development Agency-NEPAD

Updates on the Arab Drug Agency (Waad) and IPRP introduction

Representative Invited

Egyptian Drug Authority

ICH - Updates from the last ICH Assembly & Experiences of the Path from Observer to Member

Representative Invited

Have an account?

Middle East and North Africa Conference (MENA)

Session 2: International Collaboration, Harmonisation & Convergence

Session Chair(s)

Dina Fathy, MPharm, AHIP

Asmaa Fouad

Speaker(s)

Panel Discussion with Q&A

Regional Harmonisation Initiatives: The North African Medicines Reguatory Harmonisation (NA-MRH) Initiative -Challenges & Opportunities

Updates on the Arab Drug Agency (Waad) and IPRP introduction

ICH - Updates from the last ICH Assembly & Experiences of the Path from Observer to Member

Be informed and stay engaged.